WP Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
WP Advisors's GILD Position: Q3 2020 in Review
WP Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 13,446 shares — an estimated $1.03M sold.
WP Advisors first reported a position in GILD in Q4 2016 and held it in 15 quarters. The position peaked at $2.52M in Q3 2017. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- WP Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- WP Advisors sold 13,446 Gilead Sciences shares in Q3 2020, an estimated $1.03M.
- WP Advisors first reported a position in Gilead Sciences in Q4 2016 and held it in 15 quarters.
- WP Advisors's Gilead Sciences position peaked at $2.52M in Q3 2017.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on WP Advisors's 13F filing for Q3 2020, filed 16 Oct 2020.